Hypothesis: AMPK‑Driven Phosphoswitch Converts Claudin‑2 into a Selective Autophagy Cargo to Rescue Aging Gut Barrier

Rationale

The seed idea frames autophagy as a rationing system that selectively removes expendable components under siege. In aged enterocytes, chronic low‑grade mTORC1 activity and lysosomal dysfunction blunt this selectivity, leading to either insufficient claudin‑2 removal or indiscriminate degradation of barrier proteins such as occludin. We propose that a nutrient‑sensing kinase, AMPK, can re‑engage the rationing logic by phosphorylating claudin‑2 on a conserved serine residue, creating a high‑affinity LC3‑interacting region (LIR) that targets the pore‑forming protein for autophagic clearance without affecting occludin. This phosphoswitch would restore the optimal occludin/claudin‑2 ratio, lowering Na⁺/Cl⁻ permeability while preserving macromolecular barrier function, even if total protein levels remain below youthful levels.

Mechanistic Insight

1. AMPK activation (e.g., by AICAR, metformin, or exercise‑mimetic stimuli) phosphorylates claudin‑2 at Ser⁲⁰⁸ (human claudin‑2 numbering), a site predicted by NetPhos to lie within a canonical LIR motif (Φ‑X‑X‑Φ‑L‑I‑L).
2. Phosphorylation increases binding affinity of claudin‑2 for the autophagy adaptor p62/SQSTM1, as shown by surface plasmon resonance for similar phospho‑LIR motifs in other cargos.
3. Consequently, autophagosome formation preferentially engulfs phospho‑claudin‑2, delivering it to lysosomes for degradation via the ATG7/ATG16L1 pathway.
4. Simultaneously, AMPK signaling sustains ERK1/2‑mediated occludin stabilization (as observed in starvation‑induced autophagy), preventing its loss despite bulk autophagy flux.
5. The net effect is a selective reduction of the pore‑forming claudin‑2 pool, decreasing paracellular Na⁺/Cl⁻ flux, while the occludin‑dependent macromolecular seal remains intact.

Testable Predictions

• Prediction 1: In aged mouse ileum, acute AMPK activation will increase phospho‑claudin‑2 (Ser⁲⁰⁸) levels by ≥2‑fold without altering total claudin‑2 mRNA.
• Prediction 2: This phospho‑increase will correlate with enhanced co‑immunoprecipitation of claudin‑2 with p62 and increased LC3‑II clustering around tight junctions.
• Prediction 3: Functional read‑outs will show a ≥30 % reduction in FITC‑dextran (4 kDa) flux and a comparable drop in Na⁺/Cl⁻ permeability (measured by Ussing chamber short‑circuit current), while dextran ≥4 kDa permeability remains unchanged.
• Prediction 4: Genetic ablation of the phospho‑site (claudin‑2 S208A knock‑in) will abolish the barrier‑protective effect of AMPK activation, confirming causality.

Experimental Design

• Animals: 24‑month‑old C57BL/6 mice (n=8 per group) vs. 3‑month‑old young controls.
• Treatments: (i) Vehicle, (ii) AICAR (500 mg/kg i.p. daily for 3 days), (iii) AICAR + lysosomal inhibitor chloroquine (to verify autophagic flux), (iv) claudin‑2 S208A knock‑in mice receiving AICAR.
• Readouts: Western blot for total and phospho‑claudin‑2, occludin, p62, LC3‑II; immunofluorescence for tight‑junction continuity; co‑IP of claudin‑2/p62; Ussing chamber assays for TER, Na⁺/Cl⁻ flux, and FITC‑dextran (4 kDa vs. 20 kDa) permeability; qPCR for claudin‑2 and occludin transcripts.
• Statistical analysis: Two‑way ANOVA with post‑hoc Tukey; significance set at p<0.05.

Falsifiability

If AMPK activation fails to increase phospho‑claudin‑2, does not enhance claudin‑2/p62 interaction, or does not lower small‑solute permeability while leaving macromolecular flux unchanged, the hypothesis is refuted. Conversely, demonstration that the S208A mutant blocks the barrier benefit would confirm the mechanistic link.

Broader Implication

This work would reposition autophagy‑targeting interventions from indiscriminate "cleaning" to precision "rationing," suggesting that geroprotectors aiming to improve gut barrier should focus on restoring selective cargo recognition rather than merely boosting bulk autophagic flux.